Beijing Luzhu Biotechnology Co., Ltd. engages in the development, production, and sale of active pharmaceutical ingredients. It focuses on the research and development of vaccine and therapeutic bispecific antibody for human disease prevention, control, and treatment. Its products include recombinant vaccine, bispecific antibody and immunoreagent. The company was founded on November 9, 2001 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company